Patients who have the low-count chronic lymphocytic leukemia (CLL) phenotype monoclonal B-cell lymphocytosis (LC-MBL) have a nearly doubled risk for melanoma, according to a study in Journal of Clinical Oncology.
Melanoma News
Study Highlights Racial Differences in Second Primary Melanoma
White patients have the highest absolute risk for a second primary melanoma, while Black and Asian or Pacific Islander patients have the highest relative risk compared with the general population, a study analyzing Surveillance, Epidemiology, and End Results (SEER) data report.
Gene editing restores treatment sensitivity in melanoma
In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of this dangerous skin cancer that renders promising treatments ineffective.
Black Patients Have the Highest Mortality Risk For Melanoma of the Head and Neck
Black patients have the highest disease-specific mortality risk among patients with cutaneous melanoma of the head and neck, according to study findings published in the Journal of the American Academy of Dermatology.